TCRISPR

Fahreddin Palaz1,2, Mehmet Ozsoz3, Ali Zarrinpar4,5

  • 1Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

概括

基因编辑CRISPR通过修改细胞提供了治疗晚期肝癌 (HCC) 的新方法. 这项技术有望改善患者的治疗结果,克服当前治疗的局限性.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K